• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
✕
  • Home
  • News
  • Expert views
  • SPPS: Process improvements to reduce solvent consumption

SPPS: Process improvements to reduce solvent consumption

31 January 2022
Expert views

Introducing a new percolation wash concept for solid-phase peptide synthesis .[…] 

Peptides have to be washed several times during production. This still requires the use of solvents. Because green chemistry and sustainability are important to us, we compared the two washing processes – percolation and batch – and experimented with the washing volume in order to reduce the use of solvents. We noticed that the wash volume should not be changed too much, otherwise the quality of the peptides would suffer. At an endpoint of 100 ppm of residual piperidine in the discharged liquid phase, we detected that we had excellent peptide quality. At this volume, we found that compared to batch washing, percolation washing can reduce solvent use by 57 percent while maintaining the same quality. As a result, we are now routinely using percolation washing for our production across the PolyPeptide Group. By implementing this change, we reinforce our commitment to reducing the impact on the environment while maintaining the quality of our products. 

Dr R. Ravetti Duran, and Dr O. Ludemann-Hombourger, Speciality Chemicals Magazine, Jan/Feb 2022

Read more

Back to news

Related posts

2 April 2025

Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis


Read more
20 March 2025

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase


Read more
13 November 2024

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2025 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers